
Strategic partnership doubles cancer trials available to Manchester patients
In April, Manchester patients had access to twice as many cancer trials*, as a result of a new strategic partnership across five CRUK Experimental Cancer Medicine Centres (ECMCs). This figure is likely to further increase as a result of the TARGET trial.
Continue reading full article: Strategic partnership doubles cancer trials available to Manchester patients